Please note: Due to the presence of the Omicron variant and consistent with federal guidance, two monoclonal antibody (mAb) therapies, bamlanivimab/etesevimab and casirivimab/imdevimab, should no longer be used at this time.
source https://www.mass.gov/info-details/therapeutic-treatments-for-covid-19
No comments:
Post a Comment
We're away Reply You ASAP!